We found that DCs, loaded with a PD-L1 immunogen (PDL1-Vax), induced anti-PD-L1 antibody and T cell responses in immunized mice and that vaccination with PDL1-Vax DCs potently inhibited the growth of PD-L1+ tumor cells. The gene discussed is CD274; the disease is neoplasm.